Thus, lymphedema-associated Cx47 mutations in patients may not result in a loss-of-function of the Cx47 protein but may rather result in a dominant negative effect on Cx43, another connexin expressed in LECs, thereby resulting in altered function of heteromeric/heterotypic gap junctions affecting lymphatic physiology. The gene discussed is GJA1; the disease is lymphedema.